Recently, in order to better support the healthy development of the biopharmaceutical industry, PepsiCo hosted two high-end forums from August 3rd to 4th, namely the "2023 Localized Culture Medium Industrialization Dialogue" and the "Peptide Drug Development Challenge Dialogue". As an important part of the 5th CMC China in 2023, it attracted enthusiastic attention from the national media;

Xinhua News Network, Sina Network, CCTV Brand China (official website), Asia Times Network, Phoenix Network, Health Frontline, China Science and Technology News Network, West China Urban Daily, China Financial Times Network, China Economic Guide, Economic Daily (Economic Daily), Enterprise Observation Network, China Financial Times Network, China Economic News Network, Southeast Weekly, Industry and Economics Times, Biological Science Network, Global Business News Network, China Business News Network and other media platforms have all reported and promoted on a hot internet;

Biomedical industry is one of the strategic emerging industries in the country and an important support for future economic and social development. In this field, Chengdu Pepsixing Technology Industrial Co., Ltd. (hereinafter referred to as "Pepsixing") focuses on the amino acid field, focusing on the research and development, production, and sales of cell culture medium raw materials, protective amino acids, peptides, and pharmaceutical intermediates, providing high-quality raw materials and solutions for the development of the health industry. In the past 20 years, PepsiCo has been driven by innovation and quality, continuously exploring domestic and international markets, establishing good cooperative relationships with multiple countries and regions, and becoming a well-known supplier of amino acids, peptides, and pharmaceutical intermediates both domestically and internationally.

PepsiCo has built a standard GMP production workshop equipped with advanced production equipment and testing instruments. The company has a professional and dedicated R&D team and marketing team, consisting of multiple professors, PhDs, scholars, and personnel with rich relevant experience and professional knowledge. The company has a sound management and innovation system, and has passed multiple international certifications and related honorary titles. The company's main products include L-tyrosine disodium salt, alanyl-L-tyrosine, alanyl-L-cysteine, diglycopeptide, glycyl-L-tyrosine, Fmoc protective amino acid, CBZ protective amino acid, BOC protective amino acid, acetyl-L-thioproline, whey acid, D-type amino acid, and other customized pharmaceutical intermediates. The annual production reaches over 1000 tons, and the annual sales revenue is nearly 200 million yuan. The products are all produced according to the standards of the United States Pharmacopoeia (USP), European Pharmacopoeia (EP), and Japan Aji, with quality reaching the international advanced level. They are widely used in industries such as medicine, food, and cosmetics.

PepsiCo not only pursues excellence in product quality, but also constantly explores breakthroughs in product innovation. The company has multiple invention patents and utility model patents, and some products have filled the domestic gap. For example, the protective amino acids independently developed by the company are essential raw materials for the synthesis of various drugs such as tumor treatment, weight reduction and glucose reduction, immune deficiency, infectious diseases, etc. Its production process has the advantages of high utilization rate of raw materials, high product purity, less by-products, and less environmental pollution. In addition, the company has conducted in-depth research and development on products such as L-tyrosine disodium, diglycopeptide, glycyltyrosine, and alanylcysteine, exploring the physiological functions and application value of these products in culture medium raw materials, anti-inflammatory, antibacterial, antiviral, antioxidant, immune enhancement, skin whitening, memory improvement, learning ability enhancement, antidepressant, detoxification, and other aspects.

PepsiCo always aims to create an extroverted and technology-based modern enterprise, providing high-quality raw materials and solutions for fields such as human medicine, high-end food, and cosmetics with advanced technology, high-quality products, and professional services. PepsiCo not only focuses on the economic benefits of the enterprise, but also on its social responsibility. The company actively participates in social welfare activities, donates funds and materials, supports education, medical care, environmental protection and other undertakings, gives back to society, and benefits the people. PepsiCo has actively contributed to the high-quality development of the biopharmaceutical industry through innovation, contributing to the cause of human health. The story of PepsiCo is also a microcosm of China's biopharmaceutical industry. Driven by national policy support and market demand, China's biopharmaceutical industry is facing unprecedented development opportunities and challenges. As a member of this industry, PepsiCo will never forget its original intention, be brave in innovation, pursue excellence, keep up with the times, and contribute to the high-quality construction and development of the biopharmaceutical industry.